補聴器市場

出版:MarketsandMarkets

Hearing Aids Market by Product Type [Aids (Receiver,Behind the Ear, In the Canal, In the Ear Aids), Implants (Cochlear, Bone-anchored)], Type of Hearing Loss (Sensorineural, Conductive), Patient Type (Adults, Pediatrics), Region – Global Forecast to 2026

種別英文調査報告書
出版MarketsandMarkets
出版年月2021年 7月
ページ数230
図表数294

レポート目次 お問合せ

補聴器市場の[補聴器(レシーバー、耳の後ろ、外耳道、耳のエイド)、インプラント(蝸牛、骨固定)]、難聴のタイプ(感音難聴、伝導性)、患者のタイプ(成人、小児科)、地域-2026年までの世界予測

The global hearing aids market is projected to reach USD 10.2 billion by 2026 from USD 7.5billion in 2021, at a CAGR of 6.4% during the forecast period. Market growth is driven by factors such as the increasing adoption of smart hearing aids due to the rising incidence of noise-induced hearing loss, the growing prevalence of hearing loss, and technological advancements in hearing aids. On the other hand, the high cost of hearing aids and the requirement of high capital investments are the major factors hampering the growth of this market.

“The hearing implantssegment accounted for the highest growth rate in thehearing aidsmarket, by product, during the forecast period”
The hearing aids market is segmented into hearing aid devices and hearing implants based on product. In 2020, the hearing implants segment accounted for the highest growth rate in the hearing aids market.The high incidence of hearing disorders, technological advancements in hearing implants, and growth in the geriatric population are the major factors contributing to the growth of this segment. However, the high cost of these implants and the low awareness about hearing implants in emerging countries are some of the major factors that are hindering the growth of this market segment.
“Sensorineural hearing loss segment accounted for the highest CAGR”
Based on the type of hearing loss, the hearing aids market is segmented into sensorineural hearing loss and conductive hearing loss. In 2020, the sensorineural hearing loss segment accounted for the highest growth rate. This can be attributed to thehigh prevalence of sensorineural hearing loss, coupled with the growing geriatric patient pool.
“Asia Pacific: The fastest-growing regionhearing aids market”
The global hearing aids market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to register the highest CAGR during the forecast period.Factors such as the increasing prevalence of hearing loss, increasing healthcare spending, growing per capita income, and the presence of several high-growth marketsare driving the growth of the hearing aids market in this region. The low labor costs and the favorable regulatory environment in this region are also expected to propel the market growth.

The primary interviews conducted for this report can be categorized as follows:

•By Company Type: Tier 1 – 40%, Tier 2 – 30%,and Tier 3 -30%
•By Designation: C-level – 27%, D-level – 18%, and Others – 55%
•By Region: North America -51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6%, and the Middle East & Africa – 4%
Lists of Companies Profiled in the Report:

•Sonova Group (Switzerland)
•Demant A/S (Denmark)
•GN Store Nord A/S (Denmark)
•Cochlear Ltd. (Australia)
•RION Co., Ltd. (Japan)
•Starkey (US)
•Nurotron Biotechnology Co., Ltd. (China)
•MED-EL (Austria)
•Audina Hearing Instruments, Inc. (US)
•ElkonPvt. Ltd. (India)
•WS Audiology A/S (Denmark)
•Eargo, Inc. (US)
•Horentek (Italy)
•ZOUNDS Hearing Inc. (US)
•SeboTek Hearing Systems, LLC. (US)
•Arphi Electronics Private Limited (India)
•IN4 Technology Corporation (China)
•BHM-Tech ProduktionsgesellschaftmbH (Austria)
•Nano Hearing Aids (US)
•LORECas.r.o. (Turkey)
•Earlens Corporation (US)
•Austar Hearing Science and Technology (Xiamen) Co., Ltd. (China)
•Lively Hearing Corporation (US)
•audifon GmbH & Co. KG (Germany)
•Foshan Vohom Technology Co., Ltd. (China)
Research Coverage:
This report provides a detailed picture of the global hearing aidsmarket. It aims at estimating the size and future growth potential of the market across different segments, such as product, type of hearing loss, patient type,and region. The report also includes an in-depth competitive analysis ofthe key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall hearing aids market and its subsegments.It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.


目次

1INTRODUCTION32
1.1OBJECTIVES OF THE STUDY32
1.2MARKET DEFINITION32
1.2.1INCLUSIONS & EXCLUSIONS OF THE STUDY32
1.2.2MARKETS COVERED33
FIGURE 1HEARING AIDS MARKET SEGMENTATION33
1.2.3YEARS CONSIDERED FOR THE STUDY33
1.3CURRENCY34
1.4LIMITATIONS34
1.5STAKEHOLDERS34
1.6SUMMARY OF CHANGES34
2RESEARCH METHODOLOGY36
2.1RESEARCH DATA36
2.2RESEARCH APPROACH36
FIGURE 2HEARING AIDS MARKET: RESEARCH DESIGN36
2.2.1SECONDARY DATA36
2.2.1.1Key data from secondary sources37
2.2.2PRIMARY DATA38
2.2.2.1Primary sources38
2.2.2.2Key data from primary sources39
2.2.2.3Key industry insights39
2.2.2.4Breakdown of primary interviews40
FIGURE 3BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (HEARING AIDS MARKET)40
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION40
2.3MARKET SIZE ESTIMATION40
2.3.1BOTTOM-UP APPROACH41
2.3.1.1Approach 1: Company revenue estimation approach41
FIGURE 5BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH41
2.3.1.2Approach 2: Market estimation from the parent market41
FIGURE 6BOTTOM-UP APPROACH: MARKET ESTIMATION FROM THE PARENT MARKET41
2.3.1.3Approach 3: Presentations of companies and primary interviews42
2.3.1.4Growth rate assumptions42
2.3.1.5CAGR projections42
FIGURE 7CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS42

2.3.2TOP-DOWN APPROACH43
FIGURE 8HEARING AIDS MARKET: TOP-DOWN APPROACH43
2.4MARKET BREAKDOWN & DATA TRIANGULATION44
FIGURE 9DATA TRIANGULATION METHODOLOGY44
2.5ASSUMPTIONS FOR THE STUDY45
2.6LIMITATIONS45
2.7RISK ASSESSMENT46
TABLE 1RISKS ASSESSMENT46
2.8COVID-19 HEALTH ASSESSMENT46
2.9COVID-19 ECONOMIC ASSESSMENT46
FIGURE 10RECOVERY SCENARIO OF THE GLOBAL ECONOMY47
2.10ASSESSMENT OF THE IMPACT OF COVID-19 ON THE HEARING AIDS MARKET48
3EXECUTIVE SUMMARY49
FIGURE 11HEARING AIDS MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)49
FIGURE 12HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2021 VS. 2026 (USD MILLION)50
FIGURE 13HEARING AIDS MARKET, BY PATIENT TYPE, 2021 VS. 2026 (USD MILLION)50
FIGURE 14HEARING AIDS MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)51
4PREMIUM INSIGHTS52
4.1HEARING AIDS MARKET OVERVIEW52
FIGURE 15RISING PREVALENCE OF HEARING LOSS TO DRIVE THE MARKET GROWTH52
4.2HEARING AIDS MARKET SHARE, BY PRODUCT, 2021 VS. 202652
FIGURE 16HEARING AID DEVICES SEGMENT WILL CONTINUE TO DOMINATE
THE MARKET IN 202652
4.3HEARING AIDS MARKET SHARE, BY TYPE OF HEARING LOSS, 2021 VS. 202653
FIGURE 17SENSORINEURAL HEARING LOSS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD53
4.4HEARING AIDS MARKET SHARE, BY PATIENT TYPE, 2021 VS. 202653
FIGURE 18ADULT PATIENTS SEGMENT TO CONTINUE TO DOMINATE
THE MARKET IN 202653
4.5HEARING AIDS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES54
FIGURE 19ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE HEARING AIDS MARKET DURING THE FORECAST PERIOD54
5MARKET OVERVIEW55
5.1INTRODUCTION55
5.2MARKET DYNAMICS55
FIGURE 20HEARING AIDS MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES55
5.2.1DRIVERS55
5.2.1.1Growing prevalence of hearing loss55
FIGURE 21ESTIMATED NUMBER OF PEOPLE WITH DISABLING
HEARING LOSS, GLOBALLY56
FIGURE 22PREVALENCE OF HEARING LOSS, BY REGION, 201956
5.2.1.1.1Growth in the geriatric population57
FIGURE 23SHARE OF THE GLOBAL POPULATION AGED 65 AND ABOVE (2015–2019)57
5.2.1.2Technological advancements in hearing aids57
5.2.1.3Increasing adoption of smart hearing aids due to the rising incidence of noise-induced hearing loss58
5.2.2RESTRAINTS58
5.2.2.1High cost of hearing aids58
5.2.3OPPORTUNITIES59
5.2.3.1Emerging markets offer lucrative opportunities59
5.2.4CHALLENGES59
5.2.4.1Shortage of trained professionals59
5.3EPIDEMIOLOGY DATA ON HEARING LOSS AND THE ADOPTION OF
HEARING AID DEVICES60
TABLE 2GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020,
BY AGE GROUP60
TABLE 3GLOBAL NUMBER OF PEOPLE SUFFERING FROM HEARING LOSS IN 2020,
BY AGE GROUP (10-YEAR RANGE)60
TABLE 4GLOBAL NUMBER OF PEOPLE USING HEARING AID DEVICES, BY AGE GROUP61
5.4IMPACT OF COVID-19 ON THE HEARING AIDS MARKET61
5.5CASE STUDY ANALYSIS62
5.5.1CASE STUDY 1: FINDING A NEW WAY TO LISTEN TO CUSTOMERS62
5.5.2CASE STUDY 2: EFFECTIVE SERVICE DELIVERY MODELS AND REGULATIONS CAN IMPROVE ACCESS TO HEARING AIDS62
5.5.3CASE STUDY 3: OVER-THE-COUNTER HEARING AID DELIVERY CAN IMPROVE ACCESSIBILITY AND AFFORDABILITY63
5.6PESSIMISTIC AND OPTIMISTIC SCENARIOS63
5.6.1HEARING AIDS MARKET63
FIGURE 24PESSIMISTIC SCENARIO63
FIGURE 25OPTIMISTIC SCENARIO64
5.7PRICING ANALYSIS64
TABLE 5PRICE OF HEARING AIDS (2021)64
5.8PATENT ANALYSIS65
5.8.1PATENT ANALYSIS OF COCHLEAR IMPLANTS65
5.9TRADE ANALYSIS65
5.9.1TRADE ANALYSIS FOR HEARING AIDS65
TABLE 6IMPORT DATA FOR HEARING AIDS, BY COUNTRY, 2016–2020 (USD MILLION)65
TABLE 7EXPORT DATA FOR HEARING AIDS, BY COUNTRY, 2016–2020 (USD MILLION)66
5.10VALUE CHAIN ANALYSIS66
FIGURE 26MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE66
5.10.1HEARING AID DEVICES VALUE CHAIN IN THE PRIVATE SECTOR67
TABLE 8HEARING AID DEVICES VALUE CHAIN IN THE PRIVATE SECTOR67
5.11SUPPLY CHAIN ANALYSIS67
FIGURE 27HEARING AIDS MARKET: SUPPLY CHAIN ANALYSIS68
5.12ECOSYSTEM ANALYSIS OF THE HEARING AIDS MARKET69
FIGURE 28HEARING AIDS MARKET: ECOSYSTEM ANALYSIS69
5.12.1ROLE IN ECOSYSTEM69
5.13PORTER’S FIVE FORCES ANALYSIS70
TABLE 9HEARING AIDS MARKET: PORTER’S FIVE FORCES ANALYSIS70
5.13.1THREAT OF NEW ENTRANTS70
5.13.2THREAT OF SUBSTITUTES70
5.13.3BARGAINING POWER OF BUYERS70
5.13.4BARGAINING POWER OF SUPPLIERS70
5.13.5DEGREE OF COMPETITION71
5.14REGULATORY LANDSCAPE71
5.14.1NORTH AMERICA71
5.14.1.1US71
5.14.1.2Canada71
5.14.2EUROPE71
5.14.3ASIA PACIFIC71
5.14.3.1Japan71
5.14.3.2India72
5.14.4LATIN AMERICA72
5.14.4.1Brazil72
5.14.4.2Mexico72
5.14.5MIDDLE EAST72
5.15TECHNOLOGY ANALYSIS73
5.16TRENDS/DISRUPTIONS IMPACTING THE BUSINESS OF CUSTOMERS74
5.16.1REVENUE SOURCES ARE SHIFTING TOWARD MORE TECHNOLOGY-BASED SOLUTIONS DUE TO THE COVID-19 PANDEMIC74
5.16.2REVENUE SHIFT FOR THE HEARING AIDS MARKET74
6HEARING AIDS MARKET, BY PRODUCT75
6.1INTRODUCTION76
TABLE 10HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)76
TABLE 11HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)76
6.2HEARING AID DEVICES76
TABLE 12KEY PRODUCTS IN THE HEARING AID DEVICES MARKET77
TABLE 13HEARING AID DEVICES MARKET, BY REGION, 2016–2019 (USD MILLION)78
TABLE 14HEARING AID DEVICES MARKET, BY REGION, 2020–2026 (USD MILLION)78
TABLE 15HEARING AID DEVICES MARKET, BY REGION, 2016–2019 (MILLION UNITS)79
TABLE 16HEARING AID DEVICES MARKET, BY REGION, 2020–2026 (MILLION UNITS)79
TABLE 17NORTH AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (MILLION UNITS)80
TABLE 18NORTH AMERICA: HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (MILLION UNITS)80
TABLE 19EUROPE: HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (MILLION UNITS)80
TABLE 20EUROPE: HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (MILLION UNITS)81
TABLE 21APAC: HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (MILLION UNITS)81
TABLE 22APAC: HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (MILLION UNITS)82
TABLE 23HEARING AID DEVICES MARKET, BY TYPE, 2016–2019 (USD MILLION)82
TABLE 24HEARING AID DEVICES MARKET, BY TYPE, 2020–2026 (USD MILLION)83
TABLE 25HEARING AID DEVICES MARKET, BY TYPE, 2016–2019 (MILLION UNITS)83
TABLE 26HEARING AID DEVICES MARKET, BY TYPE, 2020–2026 (MILLION UNITS)83
6.2.1RECEIVER-IN-THE-EAR HEARING AIDS84
6.2.1.1RITE hearing aid devices are suitable for the treatment of
mild-to-severe hearing loss84
TABLE 27KEY PRODUCTS IN THE RECEIVER-IN-THE-EAR HEARING AIDS MARKET84
TABLE 28RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY REGION,
2016–2019 (USD MILLION)85
TABLE 29RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY REGION,
2020–2026 (USD MILLION)85
TABLE 30EUROPE: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)86
TABLE 31EUROPE: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)86
TABLE 32NORTH AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET,
BY COUNTRY, 2016–2019 (USD MILLION)87
TABLE 33NORTH AMERICA: RECEIVER-IN-THE-EAR HEARING AIDS MARKET,
BY COUNTRY, 2020–2026 (USD MILLION)87
TABLE 34APAC: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)87
TABLE 35APAC: RECEIVER-IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)88
6.2.2BEHIND-THE-EAR HEARING AIDS88
6.2.2.1Low cost of BTE devices to support the market growth88
TABLE 36KEY PRODUCTS IN THE BEHIND-THE-EAR HEARING AIDS MARKET89
TABLE 37BEHIND-THE-EAR HEARING AIDS MARKET, BY REGION,
2016–2019 (USD MILLION)89
TABLE 38BEHIND-THE-EAR HEARING AIDS MARKET, BY REGION,
2020–2026 (USD MILLION)90
TABLE 39APAC: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)90
TABLE 40APAC: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)91
TABLE 41NORTH AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)91
TABLE 42NORTH AMERICA: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)91
TABLE 43EUROPE: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)92
TABLE 44EUROPE: BEHIND-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)92
6.2.3CANAL HEARING AIDS93
6.2.3.1Technological advancements in canal hearing aids to
propel market growth93
TABLE 45KEY PRODUCTS IN THE CANAL HEARING AIDS MARKET93
TABLE 46CANAL HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION)94
TABLE 47CANAL HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION)94
TABLE 48NORTH AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)95
TABLE 49NORTH AMERICA: CANAL HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)95
TABLE 50EUROPE: CANAL HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)95
TABLE 51EUROPE: CANAL HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)96
TABLE 52APAC: CANAL HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)96
TABLE 53APAC: CANAL HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)96
6.2.4IN-THE-EAR HEARING AIDS97
6.2.4.1Longer battery life of ITE hearing devices to support
the market growth97
TABLE 54IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION)97
TABLE 55IN-THE-EAR HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION)97
TABLE 56EUROPE: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)98
TABLE 57EUROPE: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)98
TABLE 58APAC: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)99
TABLE 59APAC: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)99
TABLE 60NORTH AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)99
TABLE 61NORTH AMERICA: IN-THE-EAR HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)100
6.2.5OTHER HEARING AID DEVICES100
TABLE 62OTHER HEARING AID DEVICES MARKET, BY REGION,
2016–2019 (USD MILLION)100
TABLE 63OTHER HEARING AID DEVICES MARKET, BY REGION,
2020–2026 (USD MILLION)101
TABLE 64EUROPE: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (USD MILLION)101
TABLE 65EUROPE: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (USD MILLION)102
TABLE 66NORTH AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2016–2019 (USD MILLION)102
TABLE 67NORTH AMERICA: OTHER HEARING AID DEVICES MARKET, BY COUNTRY, 2020–2026 (USD MILLION)102
TABLE 68APAC: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2016–2019 (USD MILLION)103
TABLE 69APAC: OTHER HEARING AID DEVICES MARKET, BY COUNTRY,
2020–2026 (USD MILLION)103
6.3HEARING IMPLANTS103
TABLE 70HEARING IMPLANTS MARKET, BY REGION, 2016–2019 (USD MILLION)104
TABLE 71HEARING IMPLANTS MARKET, BY REGION, 2020–2026 (USD MILLION)104
TABLE 72EUROPE: HEARING IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)104
TABLE 73EUROPE: HEARING IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)105
TABLE 74NORTH AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)105
TABLE 75NORTH AMERICA: HEARING IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)105
TABLE 76APAC: HEARING IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)106
TABLE 77APAC: HEARING IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)106
TABLE 78HEARING IMPLANTS MARKET, BY TYPE, 2016–2019 (USD MILLION)106
TABLE 79HEARING IMPLANTS MARKET, BY TYPE, 2020–2026 (USD MILLION)107
6.3.1COCHLEAR IMPLANTS107
6.3.1.1Cochlear implants segment to dominate the hearing implants market107
TABLE 80KEY PRODUCTS IN THE COCHLEAR IMPLANTS MARKET108
TABLE 81COCHLEAR IMPLANTS MARKET, BY REGION, 2016–2019 (USD MILLION)108
TABLE 82COCHLEAR IMPLANTS MARKET, BY REGION, 2020–2026 (USD MILLION)108
TABLE 83EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)109
TABLE 84EUROPE: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)109
TABLE 85NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)109
TABLE 86NORTH AMERICA: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)110
TABLE 87APAC: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)110
TABLE 88APAC: COCHLEAR IMPLANTS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)110
6.3.2BONE-ANCHORED SYSTEMS111
6.3.2.1BAHA implants are gaining traction among children and adults with single-sided deafness and conductive hearing loss111
TABLE 89BONE-ANCHORED SYSTEMS MARKET, BY REGION,
2016–2019 (USD MILLION)111
TABLE 90BONE-ANCHORED SYSTEMS MARKET, BY REGION,
2020–2026 (USD MILLION)112
TABLE 91EUROPE: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)112
TABLE 92EUROPE: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)113
TABLE 93NORTH AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)113
TABLE 94NORTH AMERICA: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)113
TABLE 95APAC: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)114
TABLE 96APAC: BONE-ANCHORED SYSTEMS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)114
7HEARING AIDS MARKET, BY TYPE OF HEARING LOSS115
7.1INTRODUCTION116
TABLE 97HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)116
TABLE 98HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)116
7.2SENSORINEURAL HEARING LOSS116
7.2.1GROWING GERIATRIC PATIENT POOL TO SUPPORT THE GROWTH OF
THIS MARKET SEGMENT116
7.2.1.1Primary notes117
7.2.1.1.1Key industry insights117
TABLE 99HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION, 2016–2019 (USD MILLION)118
TABLE 100HEARING AIDS MARKET FOR SENSORINEURAL HEARING LOSS, BY REGION, 2020–2026 (USD MILLION)118
7.3CONDUCTIVE HEARING LOSS118
7.3.1TECHNOLOGICAL ADVANCEMENTS IN HEARING AIDS AND INCREASING PRODUCT APPROVALS TO PROPEL MARKET GROWTH118
TABLE 101HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION, 2016–2019 (USD MILLION)119
TABLE 102HEARING AIDS MARKET FOR CONDUCTIVE HEARING LOSS, BY REGION, 2020–2026 (USD MILLION)119
8HEARING AIDS MARKET, BY PATIENT TYPE120
8.1INTRODUCTION121
TABLE 103HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)121
TABLE 104HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)121
8.2ADULTS121
8.2.1HIGHER SUSCEPTIBILITY TO HEARING LOSS MAKES ADULTS A KEY SEGMENT OF THE OVERALL PATIENT POOL121
8.2.1.1Primary notes122
8.2.1.1.1Key industry insights122
TABLE 105HEARING AIDS MARKET FOR ADULT PATIENTS, BY REGION,
2016–2019 (USD MILLION)123
TABLE 106HEARING AIDS MARKET FOR ADULT PATIENTS, BY REGION,
2020–2026 (USD MILLION)123
8.3PEDIATRICS123
8.3.1TECHNOLOGICAL ADVANCEMENTS TO DRIVE THE GROWTH OF
THIS MARKET SEGMENT123
TABLE 107HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY REGION,
2016–2019 (USD MILLION)124
TABLE 108HEARING AIDS MARKET FOR PEDIATRIC PATIENTS, BY REGION,
2020–2026 (USD MILLION)125
9HEARING AIDS MARKET, BY REGION126
9.1INTRODUCTION127
TABLE 109HEARING AIDS MARKET, BY REGION, 2016–2019 (USD MILLION)127
TABLE 110HEARING AIDS MARKET, BY REGION, 2020–2026 (USD MILLION)127
9.2EUROPE128
FIGURE 29EUROPE: HEARING AIDS MARKET SNAPSHOT128
TABLE 111EUROPE: HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)129
TABLE 112EUROPE: HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)129
TABLE 113EUROPE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)129
TABLE 114EUROPE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)130
TABLE 115EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)130
TABLE 116EUROPE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)130
9.2.1GERMANY131
9.2.1.1Growth in healthcare expenditure in Germany to drive the demand for technologically advanced hearing aids131
FIGURE 30PREVALENCE OF HEARING LOSS IN GERMANY, 2015 VS. 2018131
FIGURE 31ADOPTION RATE OF HEARING AIDS BY HEARING-IMPAIRED PEOPLE IN GERMANY, 2012 VS. 2015 VS. 2018131
TABLE 117GERMANY: KEY MACROINDICATORS132
TABLE 118GERMANY: HEARING AIDS MARKET, BY PRODUCT,
2016–2019 (USD MILLION)132
TABLE 119GERMANY: HEARING AIDS MARKET, BY PRODUCT,
2020–2026 (USD MILLION)133
TABLE 120GERMANY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)133
TABLE 121GERMANY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)133
TABLE 122GERMANY: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION)134
TABLE 123GERMANY: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION)134
9.2.2UK134
9.2.2.1High and growing prevalence of hearing loss to drive market
growth in the UK134
TABLE 124UK: KEY MACROINDICATORS135
TABLE 125UK: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)135
TABLE 126UK: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)136
TABLE 127UK: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)136
TABLE 128UK: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)136
TABLE 129UK: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)137
TABLE 130UK: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)137
9.2.3FRANCE137
9.2.3.1Rising R&D expenditure in France to drive the market growth137
FIGURE 32ADOPTION RATE OF HEARING AIDS BY HEARING-IMPAIRED PEOPLE IN FRANCE, 2012 VS. 2015 VS. 2018138
TABLE 131FRANCE: KEY MACROINDICATORS138
TABLE 132FRANCE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)138
TABLE 133FRANCE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)139
TABLE 134FRANCE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)139
TABLE 135FRANCE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)139
TABLE 136FRANCE: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION)140
TABLE 137FRANCE: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION)140
9.2.4SPAIN140
9.2.4.1Increasing life expectancy and growing geriatric population to drive market growth in Spain140
FIGURE 33SPAIN: PREVALENCE OF HEARING LOSS IN 2020, BY AGE GROUP141
TABLE 138SPAIN: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)141
TABLE 139SPAIN: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)142
TABLE 140SPAIN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)142
TABLE 141SPAIN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)142
TABLE 142SPAIN: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION)142
TABLE 143SPAIN: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION)143
9.2.5ITALY143
9.2.5.1Unfavorable reimbursement scenario to restrain market growth in Italy to a certain extent143
FIGURE 34PREVALENCE OF HEARING LOSS IN ITALY, 2012 VS. 2015 VS. 2018143
FIGURE 35HEARING AIDS ADOPTION RATE IN ITALY, 2012 VS. 2015 VS. 2018144
TABLE 144ITALY: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)144
TABLE 145ITALY: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)144
TABLE 146ITALY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)145
TABLE 147ITALY: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)145
TABLE 148ITALY: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)145
TABLE 149ITALY: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)146
9.2.6REST OF EUROPE146
TABLE 150ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)146
TABLE 151ROE: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)147
TABLE 152ROE: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)147
TABLE 153ROE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)147
TABLE 154ROE: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)148
TABLE 155ROE: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)148
TABLE 156ROE: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)148
9.3NORTH AMERICA149
TABLE 157NORTH AMERICA: HEARING AIDS MARKET, BY COUNTRY,
2016–2019 (USD MILLION)149
TABLE 158NORTH AMERICA: HEARING AIDS MARKET, BY COUNTRY,
2020–2026 (USD MILLION)149
TABLE 159NORTH AMERICA: HEARING AIDS MARKET, BY PRODUCT,
2016–2019 (USD MILLION)150
TABLE 160NORTH AMERICA: HEARING AIDS MARKET, BY PRODUCT,
2020–2026 (USD MILLION)150
TABLE 161NORTH AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)150
TABLE 162NORTH AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)151
9.3.1US151
9.3.1.1The US dominated the North American hearing aids market in 2020151
FIGURE 36NUMBER OF AUDIOLOGISTS IN THE US152
TABLE 163US: KEY MACROINDICATORS153
TABLE 164US: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)153
TABLE 165US: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)153
TABLE 166US: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)154
TABLE 167US: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)154
TABLE 168US: HEARING AIDS MARKET, BY PATIENT TYPE, 2016–2019 (USD MILLION)154
TABLE 169US: HEARING AIDS MARKET, BY PATIENT TYPE, 2020–2026 (USD MILLION)155
9.3.2CANADA155
9.3.2.1Conferences, webinars, and symposia to provide impetus to the market growth155
TABLE 170CANADA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)156
TABLE 171CANADA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)156
TABLE 172CANADA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)156
TABLE 173CANADA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)157
TABLE 174CANADA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION)157
TABLE 175CANADA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION)157
9.4ASIA PACIFIC158
FIGURE 37ASIA PACIFIC: HEARING AIDS MARKET SNAPSHOT159
TABLE 176APAC: HEARING AIDS MARKET, BY COUNTRY, 2016–2019 (USD MILLION)160
TABLE 177APAC: HEARING AIDS MARKET, BY COUNTRY, 2020–2026 (USD MILLION)160
TABLE 178APAC: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)160
TABLE 179APAC: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)161
TABLE 180APAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)161
TABLE 181APAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)161
9.4.1CHINA161
9.4.1.1China dominated the APAC market for hearing aids in 2020161
TABLE 182CHINA: KEY MACROINDICATORS162
TABLE 183CHINA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)162
TABLE 184CHINA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)162
TABLE 185CHINA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)163
TABLE 186CHINA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)163
TABLE 187CHINA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION)163
TABLE 188CHINA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION)164
9.4.2INDIA164
9.4.2.1Healthcare infrastructure improvements to drive
market growth in India164
TABLE 189INDIA: KEY MACROINDICATORS165
TABLE 190INDIA: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)165
TABLE 191INDIA: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)165
TABLE 192INDIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)166
TABLE 193INDIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)166
TABLE 194INDIA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION)166
TABLE 195INDIA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION)167
9.4.3JAPAN167
9.4.3.1Rising adoption of hearing aids in the country to
support market growth167
FIGURE 38HEARING AIDS ADOPTION RATE IN JAPAN, 2012 VS. 2015 VS. 2018167
TABLE 196JAPAN: KEY MACROINDICATORS168
TABLE 197JAPAN: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)168
TABLE 198JAPAN: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)168
TABLE 199JAPAN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)169
TABLE 200JAPAN: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)169
TABLE 201JAPAN: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION)169
TABLE 202JAPAN: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION)170
9.4.4AUSTRALIA170
9.4.4.1Rising geriatric population to drive market growth in Australia170
FIGURE 39DISTRIBUTIVE SHARE OF POPULATION IN AUSTRALIA, BY AGE GROUP,
2016 VS. 2019170
TABLE 203AUSTRALIA: HEARING AIDS MARKET, BY PRODUCT,
2016–2019 (USD MILLION)171
TABLE 204AUSTRALIA: HEARING AIDS MARKET, BY PRODUCT,
2020–2026 (USD MILLION)171
TABLE 205AUSTRALIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)172
TABLE 206AUSTRALIA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)172
TABLE 207AUSTRALIA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION)172
TABLE 208AUSTRALIA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION)173
9.4.5REST OF ASIA PACIFIC173
FIGURE 40DISTRIBUTIVE SHARE OF POPULATION IN TAIWAN, BY AGE GROUP,
2016 VS. 2019174
TABLE 209ROAPAC: HEARING AIDS MARKET, BY PRODUCT, 2016–2019 (USD MILLION)174
TABLE 210ROAPAC: HEARING AIDS MARKET, BY PRODUCT, 2020–2026 (USD MILLION)175
TABLE 211ROAPAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)175
TABLE 212ROAPAC: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)175
TABLE 213ROAPAC: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION)176
TABLE 214ROAPAC: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION)176
9.5LATIN AMERICA176
9.5.1INCREASING EFFORTS TO IMPLEMENT UNIVERSAL HEALTH COVERAGE
IN THE REGION TO SUPPORT MARKET GROWTH176
FIGURE 41NUMBER OF PEOPLE WITH DISABLING HEARING LOSS IN BRAZIL AND MEXICO, 2008 VS. 2018177
TABLE 215LATIN AMERICA: HEARING AIDS MARKET, BY PRODUCT,
2016–2019 (USD MILLION)177
TABLE 216LATIN AMERICA: HEARING AIDS MARKET, BY PRODUCT,
2020–2026 (USD MILLION)178
TABLE 217LATIN AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2016–2019 (USD MILLION)178
TABLE 218LATIN AMERICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS,
2020–2026 (USD MILLION)178
TABLE 219LATIN AMERICA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION)179
TABLE 220LATIN AMERICA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION)179
9.6MIDDLE EAST & AFRICA179
9.6.1HEALTHCARE INFRASTRUCTURE IMPROVEMENTS IN THE REGION TO
DRIVE MARKET GROWTH179
TABLE 221MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PRODUCT,
2016–2019 (USD MILLION)180
TABLE 222MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PRODUCT,
2020–2026 (USD MILLION)180
TABLE 223MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2016–2019 (USD MILLION)180
TABLE 224MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY TYPE OF HEARING LOSS, 2020–2026 (USD MILLION)181
TABLE 225MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PATIENT TYPE,
2016–2019 (USD MILLION)181
TABLE 226MIDDLE EAST & AFRICA: HEARING AIDS MARKET, BY PATIENT TYPE,
2020–2026 (USD MILLION)181
10COMPETITIVE LANDSCAPE182
10.1OVERVIEW182
10.2KEY PLAYER STRATEGIES/RIGHT TO WIN182
10.2.1OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN
THE HEARING AIDS MARKET183
TABLE 227OVERVIEW OF STRATEGIES DEPLOYED BY KEY HEARING AIDS MANUFACTURING COMPANIES183
10.3REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS184
FIGURE 42REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN
THE HEARING AIDS MARKET184
10.4MARKET SHARE ANALYSIS185
FIGURE 43HEARING AIDS MARKET SHARE, BY KEY PLAYER (2020)185
TABLE 228HEARING AIDS MARKET: DEGREE OF COMPETITION185
10.5COMPANY EVALUATION QUADRANT186
10.5.1LIST OF EVALUATED VENDORS186
10.5.2STARS186
10.5.3EMERGING LEADERS187
10.5.4PERVASIVE PLAYERS187
10.5.5PARTICIPANTS187
FIGURE 44HEARING AIDS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020188
10.6COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES (2020)188
10.6.1PROGRESSIVE COMPANIES188
10.6.2STARTING BLOCKS189
10.6.3RESPONSIVE COMPANIES189
10.6.4DYNAMIC COMPANIES189
FIGURE 45HEARING AIDS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2020190
10.7COMPETITIVE BENCHMARKING190
10.7.1PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS190
FIGURE 46PRODUCT AND GEOGRAPHIC FOOTPRINT ANALYSIS OF TOP PLAYERS IN
THE HEARING AIDS MARKET190
TABLE 229PRODUCT FOOTPRINT OF COMPANIES191
TABLE 230REGIONAL FOOTPRINT OF COMPANIES191
10.8COMPETITIVE SCENARIO192
10.8.1PRODUCT LAUNCHES & REGULATORY APPROVALS192
TABLE 231KEY PRODUCT LAUNCHES & REGULATORY APPROVALS192
10.8.2DEALS193
TABLE 232KEY DEALS193
11COMPANY PROFILES194
11.1KEY PLAYERS194
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1.1SONOVA GROUP194
TABLE 233SONOVA GROUP: BUSINESS OVERVIEW194
FIGURE 47SONOVA GROUP: COMPANY SNAPSHOT (2020)195
11.1.2DEMANT A/S199
TABLE 234DEMANT A/S: BUSINESS OVERVIEW199
FIGURE 48DEMANT A/S: COMPANY SNAPSHOT (2020)200
11.1.3GN STORE NORD A/S204
TABLE 235GN STORE NORD A/S: BUSINESS OVERVIEW204
FIGURE 49GN STORE NORD A/S: COMPANY SNAPSHOT (2020)205
11.1.4COCHLEAR LTD.208
TABLE 236COCHLEAR LTD.: BUSINESS OVERVIEW208
FIGURE 50COCHLEAR LTD.: COMPANY SNAPSHOT (2020)208
11.1.5RION CO., LTD.211
TABLE 237RION CO., LTD.: BUSINESS OVERVIEW211
FIGURE 51RION CO., LTD.: COMPANY SNAPSHOT (2020)211
11.1.6STARKEY214
TABLE 238STARKEY: BUSINESS OVERVIEW214
11.1.7WS AUDIOLOGY A/S216
TABLE 239WS AUDIOLOGY A/S: BUSINESS OVERVIEW216
11.1.8NUROTRON BIOTECHNOLOGY CO., LTD.218
TABLE 240NUROTRON BIOTECHNOLOGY CO., LTD.: BUSINESS OVERVIEW218
11.1.9MED-EL219
TABLE 241MED-EL: BUSINESS OVERVIEW219
11.1.10AUDINA HEARING INSTRUMENTS, INC.220
TABLE 242AUDINA HEARING INSTRUMENTS, INC.: BUSINESS OVERVIEW220
11.1.11ELKON PVT. LTD.222
TABLE 243ELKON PVT. LTD.: BUSINESS OVERVIEW222
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
11.2OTHER PLAYERS223
11.2.1EARGO, INC.223
11.2.2HORENTEK224
11.2.3ZOUNDS HEARING INC.225
11.2.4SEBOTEK HEARING SYSTEMS, LLC.225
11.2.5ARPHI ELECTRONICS PRIVATE LIMITED226
11.2.6IN4 TECHNOLOGY CORPORATION227
11.2.7BHM-TECH PRODUKTIONSGESELLSCHAFT MBH227
11.2.8NANO HEARING AIDS228
11.2.9LORECA S.R.O.229
11.2.10EARLENS CORPORATION230
11.2.11AUSTAR HEARING SCIENCE AND TECHNOLOGY (XIAMEN) CO., LTD.230
11.2.12LIVELY HEARING CORPORATION230
11.2.13AUDIFON GMBH & CO. KG231
11.2.14FOSHAN VOHOM TECHNOLOGY CO., LTD.231
12APPENDIX232
12.1DISCUSSION GUIDE232
12.2KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL235
12.3AVAILABLE CUSTOMIZATIONS237
12.4RELATED REPORTS237
12.5AUTHOR DETAILS238


お問合せフォーム

    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com